Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Financial Results

Corona Remedies Financial Results

CORONA Remedies reported FY26 total standalone income of ₹1,413.83 Crore. The Board recommended a 100% final dividend of ₹10 per equity share.

Key figures
Value₹1,414 Cr
Source

NSE filing, NSE: CORONA. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Corona Remedies Ltd: key numbers

Share price
₹2,200.60
Market cap
₹13,459 Cr
Revenue (annual)
₹1,403 Cr
Net profit (annual)
₹185.1 Cr
P/E (TTM)
67.6×Sector 46.1×
Promoter holding
69.00%+0.00% QoQ
FII holding
4.21%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Corona Remedies Ltd

All →

Other financial results announcements

All →